Pure Global
NCT01776190

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Ben Chong·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cutaneous Lupus Erythematosus
Drug/Device/Intervention
UVA1 radiation treatment
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Ben Chong
Funder
University of Texas Southwestern Medical Center
Location
Dallas, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2012
End date
Sep 01, 2022
Enrollment
6 participants
Primary outcome

Change in Cutaneous Lupus Disease Area and Severity Index (CLASI) Activity Score

Summary

The investigators are conducting an open-label clinical trial determining the effects of UVA1
 phototherapy on cutaneous lupus (CLE) patients. Past research on systemic lupus (SLE)
 subjects indicates that this treatment is likely to be effective in treating cutaneous lupus
 with few side effects. The fact that most CLE patients are seen at dermatology clinics also
 increases the usefulness of this study because there is a large probability that phototherapy
 treatment will be accessible for many of the patients that stand to benefit from it.

ICD-10 classifications
Subacute cutaneous lupus erythematosusLupus erythematosusDiscoid lupus erythematosusSystemic lupus erythematosusSystemic lupus erythematosus, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01776190
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT01776190 through Pure Global AI's free database. This phase not specified trial is sponsored by Ben Chong and is currently Completed. The study focuses on Cutaneous Lupus Erythematosus. Target enrollment is 6 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.